SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

Published:2015-06-12 Issue:20 Volume:21 Page:4698-4708
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Zhang Xiaotun,Coleman Ilsa M.,Brown Lisha G.,True Lawrence D.,Kollath Lori,Lucas Jared M.,Lam Hung-Ming,Dumpit Ruth,Corey Eva,Chéry Lisly,Lakely Bryce,Higano Celestia S.,Montgomery Bruce,Roudier Martine,Lange Paul H.,Nelson Peter S.,Vessella Robert L.,Morrissey Colm

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer;Molecular Therapy - Nucleic Acids;2024-09

2. Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers;Cell Death & Disease;2024-08-25

3. Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis;npj Precision Oncology;2024-08-02

4. SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing;Journal of Hematology & Oncology;2024-07-30

5. Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST;Cell Death Discovery;2024-05-22